Home » Topics » Articles » Insight

Insight
RSS

Stock Indexes

March 8, 2004

BioWorld Stock Report For Public Biotechnology Companies

March 8, 2004

Stock Winners and Losers For The Week

March 8, 2004

Public Financing Of Biotechnology: February 2004

March 8, 2004

Other Financings Of Public Biotechnology Companies:February 2004

March 8, 2004

Multi-Phase III Approach Pays Off For Adolor/GSK In Entereg Efforts

March 8, 2004

By Randy Osborne

Venture Capital And Corporate Investments In Biotechnology Companies: February 2004

March 8, 2004

Stock Winners and Losers For The Week

March 1, 2004

Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Dec. 31, 2003 - Feb. 26, 2004

March 1, 2004

Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Dec. 31, 2003 - Feb. 26, 2004

March 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...